Lynne Sullivan
Director of Finance/CFO at UNITY BIOTECHNOLOGY, INC.
Net worth: 42 840 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jonathan Solomon | M | 47 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 7 years |
Nathaniel David | M | 56 | 15 years | |
Gilmore O’Neill | M | 59 | 20 years | |
Ilan Ganot | M | 50 | 11 years | |
Axel Bolte | M | 52 | 9 years | |
Anirvan Ghosh | M | 60 | 7 years | |
Jonas Grossman | M | 50 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
Caroline Dorsa | F | 64 | 14 years | |
Keith Leonard | M | 62 | 8 years | |
Alexander Cumbo | M | 53 | 2 years | |
Robert Woodman | M | 46 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 6 years |
TY Howton | M | 52 | 2 years | |
Doug Treco Treco | M | 66 | 4 years | |
Russell Greig | M | 71 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
Sarah Bhagat | M | 38 | 5 years | |
Michael Hencke | M | - | 12 years | |
William Sibold | M | 57 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | - |
Annie Ganot | F | - | 11 years | |
Clare Khan | M | 72 | 3 years | |
Alexander Nguyen | M | 47 | 3 years | |
Margo Roberts | M | 69 | 6 years | |
Sukumar Nagendran | M | 58 | 6 years | |
Georgia Keresty | M | 62 | 3 years | |
Alan Moses | M | 76 | 4 years | |
Michael Samar | M | 51 | 2 years | |
Edward Williams | M | 68 | 1 years | |
Stephen Sherwin | M | 75 | 14 years | |
Merav Bassan | M | 59 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
Martin Edwards | M | 68 | 7 years | |
Eric Rowinsky | M | 67 | 14 years | |
Paul Berns | M | 57 | 6 years | |
Reinaldo Diaz | M | 70 | 7 years | |
Ian Smith | M | 58 | 4 years | |
Glenn Pierce | M | 68 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
Camille Samuels | F | 52 | 9 years | |
Ed Mathers Mathers | M | 64 | 7 years | |
Naomi Zak | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | - |
Stefan Riley | M | - | - | |
Nicole Murphy | F | - | 9 years | |
Martin Freed | M | 63 | 6 years | |
Robert Hopfner | M | 51 | 6 years | |
Wayne I. Lencer | M | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 27 years |
Adam Stone | M | 44 | 9 years | |
David Thompson | M | - | 6 years | |
Gayle Gironda | F | - | 3 years | |
Sally McAlister | F | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | - |
Alison Kessler | F | - | 4 years | |
Yves Sabbagh | M | - | 4 years | |
Jessie Hanrahan | M | 47 | 2 years | |
Przemyslaw Sapieha | M | - | 3 years | |
Anat Primovich | M | - | 3 years | |
Ying Ming Luk | M | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
Myriam Golembo | M | 59 | 5 years | |
Sanjay Subramanian | M | 48 | 2 years | |
Natacha Gassenbach | F | - | 6 years | |
Eran Elinav | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 9 years |
Jake Elkins | M | - | 7 years | |
Robin Kramer | F | 58 | 6 years | |
Ginger Gregory | M | 56 | 7 years | |
Jessica Swann | F | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
Matthew Winton | M | 46 | 1 years | |
Assaf Oron | M | 49 | 5 years | |
Ruediger Weseloh | M | - | 18 years | |
Soo-Jin Kim | M | - | 2 years | |
Kurt C. Gunter | M | 69 | 2 years | |
Gabriel Brooks | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen DiPalma | M | 66 | 2 years | |
Adam Koppel | M | 54 | 10 years | |
Joel Schneider | M | 39 | 8 years | |
Stelios Papadopoulos | M | 75 | 15 years | |
Olaf Klinger | M | 59 | 4 years | |
Gilad D. Hayeem | M | 57 | 5 years | |
Erez Chimovits | M | 60 | 1 years | |
Gregory Covino | M | 59 | 7 years | |
Rainer Lichtenberger | M | 65 | 14 years | |
Michel Vounatsos | M | 62 | 6 years | |
James Mullen | M | 65 | 21 years | |
William Young | M | 79 | 11 years | |
Matthew Bennett Arnold | M | 55 | 8 years | |
Joan Mannick | M | 66 | 4 years | |
Jeffrey Chodakewitz | M | 68 | - | |
Friederike Rotsch | M | 51 | 18 years | |
Bernhard R. M. Ehmer | M | 69 | 20 years | |
Paul Clancy | M | 62 | 16 years | |
Richard Mulligan | M | 69 | 14 years | |
David Lacey | M | 71 | 2 years | |
Robert A. Hamm | M | 72 | 7 years | |
John J. McCabe | M | 57 | 3 years | |
Paul Sekhri | M | 66 | 2 years | |
Andrey Zarur | M | 54 | 7 years | |
Karl-Ludwig Kley | M | 73 | 10 years | |
Gbola Amusa | M | 50 | 5 years | |
Jonathan Silverstein | M | 57 | 3 years | |
Brian Posner | M | 62 | 14 years | |
Robert Nelsen | M | 60 | 9 years | |
Phillip Sharp | M | 79 | 31 years | |
Graham Cooper | M | 54 | 5 years | |
Matthew Emmens | M | 72 | 4 years | |
Craig Eric Schneier | M | 76 | 8 years | |
Lloyd Klickstein | M | 67 | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 79 | 79.00% |
Israel | 15 | 15.00% |
Germany | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lynne Sullivan
- Personal Network